Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Mar;127(3):245-51.
doi: 10.1001/archophthalmol.2008.610.

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema

Diabetic Retinopathy Clinical Research Network (DRCR.net); Roy W Beck, Allison R Edwards, Lloyd P Aiello, Neil M Bressler, Frederick Ferris, Adam R Glassman, Elizabeth Hartnett, Michael S Ip, Judy E Kim, Craig Kollman
Randomized Controlled Trial

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema

Diabetic Retinopathy Clinical Research Network (DRCR.net) et al. Arch Ophthalmol. 2009 Mar.

Abstract

Objective: To report 3-year outcomes of patients who participated in a randomized trial evaluating 1-mg and 4-mg doses of preservative-free intravitreal triamcinolone compared with focal/grid photocoagulation for treatment of diabetic macular edema.

Methods: Eyes with diabetic macular edema and visual acuities of 20/40 to 20/320 were randomly assigned to focal/grid photocoagulation or 1 mg or 4 mg of triamcinolone. At the conclusion of the trial, 3-year follow-up data were available in 306 eyes.

Results: Between 2 years (time of the primary outcome) and 3 years, more eyes improved than worsened in all 3 treatment groups. Change in visual acuity letter score from baseline to 3 years was +5 in the laser group and 0 in each triamcinolone group. The cumulative probability of cataract surgery by 3 years was 31%, 46%, and 83% in the laser and 1-mg and 4-mg triamcinolone groups, respectively. Intraocular pressure increased by more than 10 mm Hg at any visit in 4%, 18%, and 33% of eyes, respectively.

Conclusions: Results in a subset of randomized subjects who completed the 3-year follow-up are consistent with previously published 2-year results and do not indicate a long-term benefit of intravitreal triamcinolone relative to focal/grid photocoagulation in patients with diabetic macular edema similar to those studied in this clinical trial. Most eyes receiving 4 mg of triamcinolone as given in this study are likely to require cataract surgery.

Trial registration: clinicaltrials.gov Identifier: NCT00367133.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean visual acuity at each visit according to treatment group. Figure 1A: Includes all available data from all randomized eyes. Figure 1B: Includes all available data from the cohort of eyes that completed the 3 year visit.
Figure 1
Figure 1
Mean visual acuity at each visit according to treatment group. Figure 1A: Includes all available data from all randomized eyes. Figure 1B: Includes all available data from the cohort of eyes that completed the 3 year visit.
Figure 2
Figure 2
Cumulative probability of cataract surgery for all eyes phakic at baseline. The “# eyes at risk” indicates the number of eyes still in follow up at the beginning of the interval.
See this image and copyright information in PMC

References

    1. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy .IV. Diabetic macular edema. Ophthalmology. 1984;91(12):1464–74. - PubMed
    1. Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology. 1994;101(6):1061–70. - PubMed
    1. Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology. 1998;105(6):998–1003. - PubMed
    1. Diabetic Retinopathy Clinical Research Network A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology. 2008;115(9):1447–9. e1–10. 9. - PMC - PubMed
    1. Ip MS, Bressler SB, Antoszyk AN, et al. A randomized trial comparing intravitreal triamcinolone and laser photocoagulation for diabetic macular edema: Baseline features. Retina. 2008;28(7):919–30. - PMC - PubMed

Publication types

MeSH terms

Associated data